Biosimulation is a technique in which computer programs are used for the simulation of biological processes. Biosimulation has wide reaching applications in the field of drug discovery and development of new drugs. It is a tool used for prediction and biosimulation is used to predict the future outcomes of current experiments related to discovery and development of new drugs. The process of drug discovery and development is a costly one, and the failure of the drug molecule in the late phase of drug development translates into a huge wastage of time, money and other resources. Hence, there is a need of a predictive tool that will aid in predicting the future outcomes of drug development by simulation of the biological processes involved. This is the most important factor driving the global biosimulation market. The other factors supporting the growth of the biosimulation market are the increasing expenditure on healthcare, development of advanced software and improved technology related to simulation.
According to the assessment of Persistence Market Research, the global biosimulation market is forecasted to reach a figure of about US$ 1,750 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.
North America Market Set to Dominate the Global Biosimulation Market in Terms of Revenue
The market in North America is set to dominate the global biosimulation market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America biosimulation market is the most attractive market, growing at a robust CAGR over the forecast period.
Software Product Type Segment Slated to Touch a Value of About US$ 1,050 Mn in 2022
According to the projections of Persistence Market Research, the software product type segment is expected to reach a value of about US$ 1,050 Mn in the year 2022. This signifies a robust CAGR during the forecast period of 2017-2022. The software product type segment is estimated to account for nearly two-thirds of the revenue share of the product segment by the end of the year 2017 and is expected to lose in market share by 2022 over 2017.
Academic and Government Research Institutes Segment to Exhibit a CAGR of Nearly 13% During the Assessment Period
According to the assessment of Persistence Market Research, the academic and government research institutes segment is poised to touch a figure of about US$ 500 Mn in the year 2022. This signifies a CAGR of nearly 13% during the assessment period from 2017 till the year 2022. The academic and government research institutes segment is estimated to account for more than one-fourth of the revenue share of the end user segment by the end of the year 2017 and is projected to gain market share by 2022 over 2017.
The report also profiles companies that are expected to remain active in the expansion of global biosimulation market through 2022, which include Certara, L.P., Simulations Plus, Inc., Dassault Systemes SE, Schrodinger, Inc., Advanced Chemistry Development, Inc., Entelos, Inc., Evidera, Inc., Genedata AG, Leadscope Inc. and Acceryls Inc.
Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Persistence Market Research
Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Biosimulation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’. In this report, the global biosimulation market is explored in great detail, and the market dynamics of the global biosimulation market has been covered comprehensively, explaining to the report readers the drivers, restraints and trends operating in this highly competitive market. Also, analysis of the data over different parameters has been done in order to arrive at market numbers concerning the global biosimulation market. Besides, competition landscape of the global biosimulation market is also covered in this report, giving information about the key companies operating in the global biosimulation market.
In the first part of the report, the executive summary and the introduction are given. The executive summary gives a summary of the global biosimulation market and gives the pertinent market numbers that are most significant, which include the historical CAGR growth from 2012 till 2016 and the forecasted CAGR from the year 2017 till the end of the forecast period in the year 2022. Information about lucrative markets from the point of view of leading revenue share and highest CAGR are also given in the executive summary.
In the introduction section, the biosimulation market is defined in detail so that the report readers are clear about the scope of this market.
The next section of the report gives information on the key dynamics of the biosimulation market. Key points covered in this section include the global economy, fiscal stimulus and bottom line of enterprises.
In the subsequent section of the report, information is given on the cost structure analysis and pricing analysis of the global biosimulation market. An analysis on the market presence of key participants (intensity map) is also offered in this section.
The next part of the report consists of the global biosimulation market analysis and forecast by product, end user, application and region. This section of the report contains important market numbers in the form of year-on-year growth comparison, market share comparison and revenue comparison. The global biosimulation market is also analyzed across key regions- North America, Latin America, Europe, Japan, APEJ and MEA.
The last section of the report contains the competition landscape, where leading market players operating in the global biosimulation market are profiled in detail. This information is in the form of company overview, product overview, key financials and key developments pertaining to that particular company. The competition landscape also features the SWOT analysis of the selected companies, which gives the report readers information about the strengths, weaknesses, opportunities and the threats that such companies operating in the global biosimulation market are facing. The competition landscape is an invaluable part of the report as it contains all the necessary information to study the leading companies operating in the global biosimulation market and how they implement their strategies and vision to stay in the pole position in this highly competitive market.
Persistence Market Research leverages a proven and tested research methodology to determine the revenue estimations of the global biosimulation market. In-depth secondary research is used to arrive at the overall market size and top industry players. A list of industry players (manufacturers), distributors, retailers, and industry experts is developed along with a comprehensive discussion guide for detailed and exhaustive primary interviews. Data thus obtained is validated using the triangulation method, where primary and secondary research along with Persistence Market Research analysis contribute to the final data. This data is then scrutinized using advanced tools to glean pertinent insights into the global biosimulation market.